Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis

Abstract

The purpose of this study was to examine the relationship between patient management strategies employed by study personnel, and patient retention and adherence to treatment in the first year of a Phase III clinical trial of interferon beta-1b for treatment of secondary progressive multiple sclerosis (MS). Study staff from each of 35 sites were interviewed regarding patient management practices. Sites which were rated as more empathetic, as instilling a sense of purpose in the patient, and promoting less formal relationships with patients had high rates of adherence to treatment. In addressing specific patient concerns, attention to patients' emotional status and patients' expectations of trial participation were related to better adherence.

Keywords

multiple sclerosis clinical trials adherence compliance

Get full access to this article

View all access options for this article.

References

The IFNB Multiple Sclerosis Study Group . (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial . Neurology, 43: 655-661 .

Jacobs LD et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis . Ann Neurol 39: 285-294 .

Johnson KP et al. (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial . Neurology 45: 1268-1276 .

Bahlman W. (1996) Innovative combination clinical trial designs/patient compliance: A community perspective . Antiviral Res 29: 115-117 .

Probstfield JL et al. (1986) Successful program for recovery of dropouts to a clinical trial . Am J Med 80: 777-784 .

Mohr DC. (1995) Negative outcome in psychotherapy: A critical review . Clin Psychol Sci Practice 2: 1-27 .

Mohr DC et al. (1996) Therapeutic expectations of patients with multiple sclerosis upon initiating inter-feron beta-1b: Relationship to adherence to treatment . Multiple Sclerosis 2: 222-226 .

DiMatteo MR , Reiter RC , Gambone JC. (1994) Enhancing medication adherence through communication and informed collaborative choice . Health Commun 6: 253-265 .

Hall JA , Roter DL , Katz NR. (1987) Task versus socio-emotional behaviors in physicians . Med Care 25: 399-412 .

10.

Probstfield JL , Russell ML , Insull WJ , Yusuf S. (1990) Dropouts from a clinical trial, their recovery and characterization: a basis for dropout management and prevention. In: Shumaker SA , Schron EB , Okene JK , (eds). The handbook of health behavior change. New York: Springer .

11.

Mohr DC et al. (1997) Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis . Arch Neurol 54: 531-533 .